A composition for use in the treatment of fistula, the composition comprising activated carbon.

The present invention concerns a method for producing a hydrogel comprising the following steps in succession: a first step (i) of providing at least one powder of an anionic polymer (A) and at least one chitosan powder (B) comprising amine functions (NH.sub.2); a second step (ii) consisting in dry mixing at least the powders (A) and (B) from the first step in order to form a mixture of powders; a third step (iii) of suspending the mixture of powders obtained from the second step in an aqueous medium having a pH that can enable the anionic polymer (A) to be dissolved without dissolving the chitosan (B); a fourth step (iv) of adding an acid to the suspension obtained from the third step in order to form the hydrogel; or the third (iii) and fourth (iv) steps are replaced by a mixing fifth step (v), comprising mixing an acidified aqueous medium including at least one compound (C) comprising at least one unit of a hexose or a unit derived from a hexose, and/or at least one phosphate of said compound (C), with said mixture comprising at least the powders (A) and (B) obtained from the second step (ii).

An arrangement comprising an optical element and an indication member for a drug delivery device is provided. The indication member comprises a plurality of indicia. The optical element comprises an imaging section and a light-transmissive non-imaging section, wherein the indication member is movable with respect to the optical element such that the indicia can be successively moved into a display position relative to the optical element. The imaging section is configured such that, when a first indicium is arranged in the display position, the first indicium is imaged by the imaging section into an imaging solid angle. The non-imaging section is configured such that light defining a second indicium is deflected by the non-imaging section such that the second indicium cannot be identified by a user in the imaging solid angle on a viewing side of the optical element.

The present invention relates to a display arrangement for a drug delivery device, comprising: a first display member comprising numerous surface portions having at least two different but interrelated appearances and being alternately arranged along a first direction, and a second display member comprising a light modulating structure to modulate visible light emanating from the first display member, wherein first and second display members are movably disposed relative to each other along the first direction to simultaneously reveal and/or to conceal at least two surface portions of interrelated appearance.

A syringe including a barrel having an internal reservoir for containing a volume of medication, a plunger received within the barrel and axially moveable relative thereto to change the volume of the medication in the reservoir, a first set of indicia marked on the barrel indicating volumetric dosage of the medication calibrated based on a predetermined patient characteristic, and a second set of indicia marked on the barrel having a correlation with the first set of indicia, the second set of indicia indicating volumetric dosage of the medication calibrated based on a medication unit of measurement. A kit including a syringe and a pre-filled medication container calibrated based on a patient characteristic.

A wound irrigation device, comprising: a cap structure configured to engage a bottle containing an irrigation solution at a first end; a protective rim disposed about a periphery of the cap structure at a second end, wherein the protective rim is selectively disposed about or in proximity to a wound to be irrigated when in use; one or more conduits for selectively communicating a compressed gas through the cap structure and into an interior of the bottle to form a compressed irrigation solution; and a longitudinal wall structure disposed within the cap structure and defining one or more channels for selectively communicating the compressed irrigation solution through the cap structure and to the wound. The wound irrigation device further comprising a vent conduit in fluid communication with the one or more conduits for selectively venting the compressed gas through the cap structure and into the environment.

Described are devices, systems, and methods for processing adipose tissue for reintroduction into a body. In some embodiments, adipose tissue is mixed with an additive prior to reintroduction.

An apparatus for determining the volume of a liquid in a container. A digital camera is provided to view the container. A processor can optically detect certain characteristics of the container as viewed by the camera and accesses a computer memory having stored characteristics of a plurality of known containers, and the compare the detected certain characteristics with the stored characteristics to identify the container from the plurality of known containers. The processor can calculate the volume of the container as a function of the distance between the first and second ends of the container as viewed by the camera. The processor can receive at least one image from the camera and determine whether the liquid in the container contains any air pockets based on the at least one image. Methods are provided, including a method for use by an apparatus having a camera and a processor electrically coupled to the camera to confirm the dosage of a medicament in a container.

An article is described including an article surface and a coating set comprising an optional tie coating or layer, a barrier coating or layer, and a pH protective layer. The respective coatings or layers can be applied by chemical vapor deposition of a polysiloxane or polysilazane precursor in the presence of oxygen. Examples of such an article are a prefilled thermoplastic syringe or thermoplastic pharmaceutical vial with a coated interior portion containing a pharmaceutical preparation or other fluid with a pH of 4 to 8, alternatively 5 to 9. The barrier coating or layer prevents oxygen from penetrating into the thermoplastic syringe or vial. The tie coating or layer, if present, and the pH protective coating or layer protect the barrier layer from the contents of the syringe or vial.

An article is described including an article surface and a coating set comprising an optional tie coating or layer, a barrier coating or layer, and a pH protective layer. The respective coatings or layers can be applied by chemical vapor deposition of a polysiloxane or polysilazane precursor in the presence of oxygen. Examples of such an article are a prefilled thermoplastic syringe or thermoplastic pharmaceutical vial with a coated interior portion containing a pharmaceutical preparation or other fluid with a pH of 4 to 8, alternatively 5 to 9. The barrier coating or layer prevents oxygen from penetrating into the thermoplastic syringe or vial. The tie coating or layer, if present, and the pH protective coating or layer protect the barrier layer from the contents of the syringe or vial.